Paragon Genomics is Discovery Tools (Healthcare) in United States that focus on target enrichment technologies business. Founded in 2015. They cover business area such as developer, target sequencing technology, target enrichment solution, precision medicine, research, comprehensive solution, precision diagnostic, oncology, infectious disease, inherit disease, reproductive health, neurology, cardiology, many other application, NGS lab, targeted sequencing assay.
2015
( 9 years old in 2024 )
Target Enrichment Technologies
-
3521 Investment Boulevard
Suite 1
Hayward, CA 94545
United States
Private
developertarget sequencing technologytarget enrichment solutionprecision medicineresearchcomprehensive solutionprecision diagnosticoncologyinfectious diseaseinherit diseasereproductive healthneurologycardiologymany other applicationNGS labtargeted sequencing assay
* We use standard office opening hours in near Paragon Genomics's location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
Paragon Genomics is Discovery Tools (Healthcare) business from United States that founded in 2015 (9 years old in 2024), Paragon Genomics business is focusing on Target Enrichment Technologies.
Paragon Genomics headquarter office and corporate office address is located in 3521 Investment Boulevard Suite 1 Hayward, CA 94545 United States.
Paragon Genomics was founded in United States.
In 2024, Paragon Genomics is currently focus on target enrichment technologies sector.
Above is snippet of Google Trends for "target enrichment technologies" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with Paragon Genomics, any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.
